Cargando…

Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications

PURPOSE: The thermodynamically favored complex between the nuclear vitamin D receptor (VDR) and 1α,25(OH)(2)-vitamin D(3) (1,25D3) triggers a shift in equilibrium to favor VDR binding to DNA, heterodimerization with the nuclear retinoid x receptor (RXR) and subsequent regulation of gene transcriptio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaghmaei, Sepideh, Roberts, Christopher, Ai, Rizi, Mizwicki, Mathew T, Chang, Chia-en A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215818/ https://www.ncbi.nlm.nih.gov/pubmed/25505647 http://dx.doi.org/10.1186/2193-9616-1-2

Ejemplares similares

Structural and Energetic Effects of A(2A) Adenosine Receptor Mutations on Agonist and Antagonist Binding
por: Keränen, Henrik, et al.
Publicado: (2014)

CCR5 and CXCR4 antagonist and agonist binding sites
por: Teintze, Martin, et al.
Publicado: (2006)

Conformational dynamics of androgen receptors bound to agonists and antagonists
por: Gim, Hyo Jin, et al.
Publicado: (2021)

Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores
por: Lagarde, Nathalie, et al.
Publicado: (2016)

An agonist–antagonist cerebellar nuclear system controlling eyelid kinematics during motor learning
por: Sánchez-Campusano, Raudel, et al.
Publicado: (2012)

In vitro assessment of pesticides capacity to act as agonists/antagonists of the thyroid hormone nuclear receptors
por: Zekri, Yanis, et al.
Publicado: (2021)

In vitro assessment of pesticides capacity to act as agonists/antagonists of the thyroid hormone nuclear receptors
por: Zekri, Yanis, et al.
Publicado: (2021)

Elucidation of Agonist and Antagonist Dynamic Binding Patterns in ER-α by Integration of Molecular Docking, Molecular Dynamics Simulations and Quantum Mechanical Calculations
por: Sakkiah, Sugunadevi, et al.
Publicado: (2021)

Dynamical Binding Modes Determine Agonistic and Antagonistic Ligand Effects in the Prostate-Specific G-Protein Coupled Receptor (PSGR)
por: Wolf, Steffen, et al.
Publicado: (2017)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

The Agonist-antagonist Myoneural Interface
por: Herr, Hugh, et al.
Publicado: (2021)

Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists
por: Lee, Sehan, et al.
Publicado: (2017)

T-Analyst: a program for efficient analysis of protein conformational changes by torsion angles
por: Ai, Rizi, et al.
Publicado: (2010)

Spatiotemporal dynamics of self-assembled structures in enzymatically induced agonistic and antagonistic conditions
por: Priyanka,, et al.
Publicado: (2021)

Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
por: Li, Zoe, et al.
Publicado: (2023)

Molecular sampling of the allosteric binding pocket of the TSH receptor provides discriminative pharmacophores for antagonist and agonists
por: Hoyer, Inna, et al.
Publicado: (2013)

Acute Effects of Different Agonist and Antagonist Stretching Arrangements on Static and Dynamic Range of Motion
por: Amiri-Khorasani, Mohammadtaghi, et al.
Publicado: (2015)

Evidence for biased agonists and antagonists at the endothelin receptors
por: Maguire, Janet J.
Publicado: (2016)

Multitargeting nature of muscarinic orthosteric agonists and antagonists
por: Myslivecek, Jaromir
Publicado: (2022)

Non-Peptide Agonists and Antagonists of the Prokineticin Receptors
por: Lattanzi, Roberta, et al.
Publicado: (2022)

Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
por: Nock, Berthold A., et al.
Publicado: (2023)

Molecular dynamics of the ERRγ ligand-binding domain bound with agonist and inverse agonist
por: Sasidharan, Santanu, et al.
Publicado: (2023)

Discovery of novel oestrogen receptor α agonists and antagonists by screening a revisited privileged structure moiety for nuclear receptors
por: Masuya, Takahiro, et al.
Publicado: (2019)

Agonistic and antagonistic estrogens in licorice root (Glycyrrhiza glabra)
por: Simons, Rudy, et al.
Publicado: (2011)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
por: Tsukahara, Tamotsu
Publicado: (2012)

Muscle agonist–antagonist interactions in an experimental joint model
por: Gorkovenko, Andrei V., et al.
Publicado: (2012)

Novel RAAS agonists and antagonists: clinical applications and controversies
por: Romero, Cesar A., et al.
Publicado: (2015)

Discovery of GPR183 Agonists Based on an Antagonist Scaffold
por: Kjær, Viktoria M. S., et al.
Publicado: (2021)

STING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments
por: Guerini, Danilo
Publicado: (2022)

Potential Therapeutic Applications of N-Cadherin Antagonists and Agonists
por: Blaschuk, Orest W.
Publicado: (2022)

Comparative proteomics reveal negative effects of gonadotropin-releasing hormone agonist and antagonist on human endometrium
por: Chen, Qian, et al.
Publicado: (2019)

Molecular Recognition of Agonist and Antagonist for Peroxisome Proliferator-Activated Receptor-α Studied by Molecular Dynamics Simulations
por: Liu, Mengyuan, et al.
Publicado: (2014)

Elucidating Binding Sites and Affinities of ERα Agonists and Antagonists to Human Alpha-Fetoprotein by In Silico Modeling and Point Mutagenesis
por: Moldogazieva, Nurbubu T., et al.
Publicado: (2020)

Standing task difficulty related increase in agonist-agonist and agonist-antagonist common inputs are driven by corticospinal and subcortical inputs respectively
por: Nandi, Tulika, et al.
Publicado: (2019)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
por: Peeters, Frederique E. C. M., et al.
Publicado: (2018)

Development of selective agonists and antagonists of P2Y receptors
por: Jacobson, Kenneth A., et al.
Publicado: (2008)

Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
por: Manning, M, et al.
Publicado: (2012)

QSPR analysis of some agonists and antagonists of α-adrenergic receptors
por: Kawczak, Piotr, et al.
Publicado: (2014)

Cheminformatics analysis of the AR agonist and antagonist datasets in PubChem
por: Hao, Ming, et al.
Publicado: (2016)

Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists
por: Anderson, Ross C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4fd2vj64ja8kb7l5u2eaum2p06